96768 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
Sub-classes:PH-SENSITIVE MEMBRANE DISRUPTIVE PEPTIDES AND USE THEREOF
#2CYCLIC CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF
#3EPHA4 ANTAGONISTS AND USES THEREOF
#4SYNTHETIC ANTIMICROBIAL PEPTIDES
#5LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES
#6METHOD FOR INTRODUCING NUCLEIC ACID INTO MITOCHONDRION
#7METHOD FOR PREVENTING FORMATION OF AMYLOID B AGGREGATION AND TREATING AMYLOIDOSIS BY USING SYNTHETIC PEPTIDE
#8CYCLIC CELL-PENETRATING PEPTIDES AND USES THEREOF
#9METHODS AND COMPOSITIONS FOR USING LEUCINE ZIPPERS FOR CROSSLINKING OF CELLS AND DRUG CARRIERS
#10Synthesis of GLP-1R/GIPR Agonists and Precursors Thereof
#11PROTEIN-ENGINEERED PHOTORESPONSIVE CONDUCTIVE NANOFIBERS
#12FORMULATION FOR WOUND HEALING
#13CELL FREE VASCULAR GRAFTS AND GRAFT MATERIALS FOR CELLULAR RECRUITMENT
#14DRUG DELIVERY METHODS AND COMPOSITIONS
#15POLYPROLINE NANOCAGE COMPOUND AND MANUFACTURING METHOD THEREOF
#16STAPLED PEPTIDE AND USE THEREOF
#17COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS
#18PEPTIDE COMPOSITIONS AND METHODS OF USE
#19SELF-ASSEMBLING PEPTIDE SCAFFOLD
#20HIGH AFFINITY VARIANTS OF SH2 DOMAINS
#21PHARMACEUTICAL USE OF POLYPEPTIDE IN PREPARATION OF DRUGS FOR TREATING AND/OR PREVENTING DIABETES AND OBESITY AND RELATED DISEASES THEREOF
#22METHOD OF TREATMENT OF NEUTROPHIL-DRIVEN INFLAMMATORY PATHOLOGIES
#23PEPTIDE COMPOSITIONS AND METHODS OF USE
#24B7-H3 MINIPROTEINS, CONJUGATES, AND USES THEREOF
#25NOVEL ANTIGENS FOR CANCER AND USES THEREOF
#26SLIDING BIOACTIVE PEPTIDES FOR THERAPEUTIC DELIVERY
#27USE OF PEPTIDES IN FABRIC FINISHING FORMULATIONS FOR COLOR CARE
#28USE OF PEPTIDES IN FABRIC FINISHING FORMULATIONS FOR COLOR CARE
#29POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES
#30ARTIFICIAL INTELLIGENCE-GUIDED PROTEIN DESIGN FOR NANOVESICLE ANALYSIS AND ENGINEERING
#31METHODS AND COMPOSITIONS REGARDING CYCLIC PEPTIDES FOR USE WITH ANTIBODIES AND ANTIBODY FRAGMENTS
#32ANALGESIC POLYPEPTIDE
#33COMPOSITIONS AND METHODS COMPRISING EPITOPES AND POLYPEPTIDES
#34ENHANCED PEPTIDE CONSTRUCTS FOR ALBUMIN BINDING
#35CYCLIC CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF
#36ANTIBODY-RECRUITING MOLECULES
#37MECP2 BASED THERAPY
#38PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST
#39NOVEL ALPHA-FACTOR BASED PEPTIDES WITH ANTIFUNGAL ACTIVITY
#40ANTIMICROBIAL PEPTIDES AGAINST CITRUS GREENING
#41SHORT SYNTHETIC PEPTIDES AND USES THEREOF IN THE TREATMENT OF ENTEROVIRUS INFECTION
#42PEPTIDE DRUGS FOR SUPPRESSING TOLERANCE DEVELOPMENT BY BLOCKING HOMO- AND HETERO-DIMERIZATION OF OPIOID RECEPTORS
#43COMPOUND HAVING AFFINITY SUBSTANCE TO ANTIBODY AND BIOORTHOGONAL FUNCTIONAL GROUP, OR SALT THEREOF
#44CLEC9A-BASED CHIMERIC PROTEIN COMPLEXES
#45IMMUNORECEPTOR INHIBITORY PROTEINS AND RELATED METHODS
#46VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 (VEGFR-1) INHIBITORS FOR PROMOTING MYELINATION AND NEUROPROTECTION
#47PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ACUTE MYELOID LEUKEMIA (AML) AND OTHER HEMATOLOGICAL NEOPLASMS
#48LIQUID DETERGENT AND UNIT DOSE DETERGENT COMPOSITIONS AND METHODS OF USING THE SAME
#49CHIMERIC SMALL MOLECULES FOR LABELING PROTEINS WITH IMMUNOGENIC MOIETIES AND METHODS OF USE THEREOF
#50DIETARY SUPPLEMENTS, COMPOSITIONS, AND USES THEREOF FOR INCREASING TELOMERASE ACTIVITY AND EXTENDING TELOMERE LENGTH
#51NOVEL POLYPEPTIDES
#52USE OF NON-INFORMATIONALAMINO ACID CHAINS TO MODIFY THE SOLUBILITY PROPERTIES OF PEPTIDES
#53CALPROTECTIN BINDING PEPTIDES
#54NOVEL POLYPEPTIDES
#55PEPTIDE ANALOG WITH ANTI-INFLAMMATORY ACTIVITY AND ITS PREPARATION METHOD AND APPLICATION
#56PROTEINS TOXIC TO HEMIPTERAN INSECT SPECIES
#57Compositions and Methods for Modulating Circulating Factors
#58TRANSMEMBRANE PEPTIDIC ANTAGONISTS OF PLEXIN-A1 AND THEIR THERAPEUTIC USES
#59LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE
#60V.kappa.4-1-IGLC Polypeptide and Use Thereof
#61HIGH AFFINITY PURIFICATION OF FERRITIN
#62ARTICLES AND METHODS FOR INHIBITING METHIONINE AMINOPEPTIDASE ACTIVITY
#63COMPOUND HAVING AFFINITY SUBSTANCE TO ANTIBODY AND BIOORTHOGONAL FUNCTIONAL GROUP, OR SALT THEREOF
#64ANTIMICROBIAL PEPTIDES FOR REMINERALIZATION OF TEETH AND PREVENTION OF DENTAL CARIES
#65PEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF
#66PEPTIDE COMPOUNDS AND PEPTIDE CONJUGATES FOR THE TREATMENT OF CANCER THROUGH RECEPTOR-MEDIATED CHEMOTHERAPY
#67PEPTIDE-DRUG CONJUGATES AND USES THEREOF
#68PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST
#69COMPOSITIONS AND METHODS FOR REDUCING ICE CRYSTAL FORMATION
#70ENGINEERED SYNTHETIC PEPTIDES, COMPOSITIONS COMPRISING SAME, AND METHODS OF USE THEREOF FOR TREATING MALIGNANT GLIOMAS
#71PEPTIDES FOR THE TREATMENT OF RESPIRATORY INFECTIONS OF VIRAL ORIGIN
#72SYNTHETIC ANTIMICROBIAL PEPTIDES
#73COMPOSITIONS AND METHODS FOR ANTI-PHOSPHOCHOLINE ACTIVE IMMUNOTHERAPY
#74ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES AND METHODS OF USE
#75PEPTIDES FOR PROMOTING HAIR FOLLICLE NEOGENESIS, AND PREVENTION/MITIGATION OF UNTOWARD EFFECTS OF RADIATION TREATMENT
#76INSILICO METHOD AND SYSTEM FOR DESIGNING A BASELINE PEPTIDE BIORECEPTOR FOR SENSING A BIOMARKER FOR DYSGLYCEMIC DISORDERS
#77PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST
#78PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST
#79A SYNTHETIC SYSTEM FOR TUNABLE THRESHOLDING OF PROTEIN SIGNALS
#80Systems and Methods for Detecting Fibrosis
#81AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#82MEMBRANE-PENETRATING PEPTIDES TO ENHANCED TRANSFECTION AND COMPOSITIONS AND METHODS FOR USING SAME
#83BIFUNCTIONAL PEPTIDE WITH MUCOADHESIVE AND VIRUS BINDING PROPERTIES
#84ACTIVATION OF THE INSULIN RECEPTOR BY AN INSULIN MIMETIC PEPTIDE
#85SYNTHESIS OF SELF-ASSEMBLING ARTIFICIAL PROTEINS UTILIZING A HOST-GUEST SYSTEM AND USES THEREOF
#86DE NOVO DESIGNED BINDERS TARGETING HUMAN EPCAM AND PDL1 RECEPTORS
#87PROCESSES AND INTERMEDIATES FOR PREPARING TIRZEPATIDE
#88Antibacterial Chimeric Peptides and Their Methods of Therapeutic Use
#89MINIPROTEINS, CONJUGATES & USES THEREOF
#90De Novo Designed Stimulus-responsive Two-state Hinge Proteins
#91SYNTHETIC POLYPEPTIDES AND USES THEREOF
#92SECRETION-OPTIMIZED DE NOVO DESIGNED PROTEIN NANOPARTICLES FOR EUKARYOTIC EXPRESSION AND GENETIC DELIVERY
#93USE OF BIOACTIVE POLYPEPTIDE SYNTHESIZED ON BASIS OF KDM2B SEQUENCE IN NEURAL DIFFERENTIATION AND REGENERATION AND REPAIR OF MESENCHYMAL STEM CELLS
#94Control of Copolymer Compositions
#95COMPOSITIONS AND METHODS FOR SELECTIVE DEPLETION OF TARGET MOLECULES
#96De novo Design of Protein Switches
#97PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS
#98COMPOUNDS AND METHODS FOR LIQUID PHASE SYNTHESIS
#99KERATINOCYTE GROWTH FACTOR (KGF)-TRANSDERMAL PEPTIDE (TP) FUSION PROTEIN, AND PREPARATION AND APPLICATION THEREOF
#100Alpha-sheet Polypeptides and Their Use
#101BETA-CATENIN PROTEIN DEGRADATION
#102FUSOGENIC PEPTIDE COMPOSITIONS AND METHODS OF CARGO DELIVERY
#103PHARMACEUTICAL FORMULATIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS
#104POLYPEPTIDE, PHOTORESIST COMPOSITION INCLUDING THE SAME, AND METHOD OF FORMING PATTERN USING THE SAME
#105Ligand Operable Protein Cages
#106METHOD OF PRODUCING PEPTIDE DERIVED FROM CHAPERONIN 60.1
#107INHIBITION OF TREM RECEPTOR SIGNALING WITH PEPTIDE VARIANTS
#108RAPID, COMPREHENSIVE AND SENSITIVE METHOD FOR NEOANTIGEN SCREENING FROM RECURRENT CANCER MUTATIONS
#109Protein Thermostability Reduction by Tag Fusion and Its Usage
#110METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#111Compositions And Methods For Making And Using Atherosclerotic Nanomatrix Vascular Sheets
#112PHARMACEUTICALS AND DEVICES FOR THE COVALENT IMMOBILIZATION TO THE EXTRACELLULAR MATRIX BY TRANSGLUTAMINASE
#113LIVER-TARGETED DRUG AND USE THEREOF
#114MEMBRANE-PENETRATING PEPTIDES TO ENHANCED TRANSFECTION AND COMPOSITIONS AND METHODS FOR USING SAME
#115ANTIBODY-PEPTIDE FUSION PROTEINS FOR TREATING AMYLOID DISORDERS
#116MULTIVALENT ANTIBODY RECRUITMENT MOLECULES
#117METHODS OF TREATING HEMOPHILIA A
#118NEW PEPTIDE AND USES THEREOF
#119PROTEIN SCAFFOLD CAPABLE OF CARRYING RADIOACTIVE SIGNALS AND APPLICATION IN ANTIBODY DETECTION
#120NEW PEPTIDE AND USES THEREOF
#121SYNTHETIC TRANSCRIPTION FACTORS
#122ANTIMICROBIAL PEPTIDES AND METHODS OF USING SAME
#123USE OF SE-DR AFFINITY PEPTIDE IN PREPARING DRUG FOR TREATING RHEUMATIC DISEASE
#124TDP-43 Interference Peptides, Methods, and Uses Thereof
#125POLYPEPTIDE AND APPLICATION THEREOF IN PREPARATION OF ANTI-FIBROSIS DRUG
#126CH1 DOMAIN AFFINITY LIGANDS AND AGENTS
#127METHODS OF FORMING RADIOPAQUE PEPTIDES AND MEDICAL HYDROGELS FORMED THEREFROM
#128FLUORESCENT BIOSENSOR FOR ACETYL COENZYME A
#129EXTENDED RECOMBINANT POLYPEPTIDES AND COMPOSITIONS COMPRISING SAME
#130PEPTIDES AND METHODS FOR USE IN TREATING PAIN
#131DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF
#132RAPID, GREEN, DISULFIDE BOND FORMATION IN WATER USING DICYANOCOBINAMIDE
#133PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF MAKING AND USING THEREOF
#134FUSION PROTEINS
#135SELF-ASSEMBLING PEPTIDES WITH HYALURONIC ACID BINDING DOMAINS AND METHODS OF USE THEREOF
#136NOVEL SENOTHERAPY PEPTIDE AND COMPOSITION CONTAINING THE SAME
#137DELIVERY OF ANITSENSE OLIGOMERS BY MIRROR IMAGE PEPTIDES
#138FILMS FORMED FROM SELF-ASSEMBLING PEPTIDE HYDROGELS
#139DUAL TARGETING FOR CELL-SPECIFIC DELIVERY TO THE CENTRAL NERVOUS SYSTEM
#140ENGINEERED BACTERIAL RIBOSOME COMPOSITIONS AND METHODS
#141CHIMERIC PEPTIDE-MODIFIED SIS MEMBRANE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#142TRICYCLIC POLYPEPTIDE CONJUGATED DRUG AND USE THEREOF
#143Polypeptide with anti-activity, and preparation method and use thereof
#144CYCLIC POLYPEPTIDE CARRIER FOR EFFICIENT DELIVERY OF NUCLEIC ACID, AND VARIANTS THEREOF
#145Processes and intermediates for preparing tirzepatide
#146PEPTIDE FOR PENETRATING BLOOD-BRAIN BARRIER AND USE THEREOF
#147TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME
#148PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST
#149PEPTIDE CROSSLINKING AGENT AND CROSSLINKED PEPTIDE WHICH IS CROSSLINKED USING SAID CROSSLINKING AGENT
#150Esterified Protein and Production Method Thereof
#151TREATING MULTIPLE MYELOMA
#152Activin Type 2 Receptor Binding Proteins and Methods of Making Them
#153PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST
#154CONJUGATED VACCINE CARRIER PROTEINS
#155NOVEL PEPTIDES & COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML & OTHER CANCERS
#156Fusion protein and its preparation method for intermediate polypeptide of Semaglutide
#157USE OF PROTON PUMP MODULATOR IN PREPARING REAGENT
#158HETEROTANDEM BICYCLIC PEPTIDE COMPLEX
#159METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#160Variants of Ankyrin Repeat Domains
#161MODULATION OF MAMMALIAN CELL LINEAGE BY SYNTHETIC IMMODULINS
#162PEPTIDES AND ANTIGEN BINDING PROTEINS FOR USE IN IMMUNOTHERAPY AGAINST FIBROLAMELLAR HEPATOCELLULAR CARCINOMA (FL-HCC) AND OTHER CANCERS
#163HIGH DENSITY PEPTIDE POLYMERS
#164Immunomodulatory Therapy For Type 1 Diabetes Mellitus Autoimmunity
#165SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE
#166SYNTHETIC DNA BINDING DOMAIN PEPTIDES AND USES THEREOF
#167NOVEL PEPTIDES AND USES THEREOF FOR TREATING CANCER
#168PEPTIDE CARRIERS AND DELIVERY TO THE EYE OF A SUBJECT
#169ANTIBODIES SPECIFIC FOR STRUCTURALLY DISORDERED SEQUENCES
#170NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#171COMPOSITIONS AND METHODS FOR DISSOLVING PROTEIN AGGREGATES
#172STABILIZED PEPTIDES FOR COVALENT BINDING TO TARGET PROTEIN
#173CONSTRAINED PEPTIDES
#174COVALENT HETEROCYCLES AND USES THEREOF
#175SYMMETRIC PROTEINS
#176ANTIMICROBIAL PEPTIDE OR PEPTIDE DERIVATIVE, SUBSTITUTE, AND COMPOSITION THEREOF, AND PREPARATION METHOD AND APPLICATION OF COMPOSITION
#177FUNCTIONAL THERAPEUTIC INDEX IN THE TREATMENT OF PERIPHERAL IMMUNE DYSFUNCTION
#178Rippled Antiparallel Cross-Beta Dimers and Related Materials, Compositions and Methods
#179PROTEIN THAT SIMULTANEOUSLY AND POTENTLY BINDS TO BOTH MCL-1 AND BCL-xL AND USES THEREOF
#180PREPARATION AND APPLICATION OF POLYPEPTIDE
#181CYCLOTIDES IN COMBINATION WITH KAPPA OPIOID RECEPTOR LIGANDS FOR MS THERAPY
#182Proteins toxic to Hemipteran insect species
#183POLYPEPTIDES AND USES THEREOF
#184G4-SPECIFIC PEPTIDES AND METHODS OF IDENTIFYING THE SAME
#185STAPLED ANTIMICROBIAL PEPTIDES (STAMPS) AND USES THEREOF
#186CYSTINE KNOT SCAFFOLD PLATFORM
#187METHOD OF SYNTHESIZING DENDRIMERIC AMPHIPHILE
#188COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS
#189MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF
#190ACTIVATABLE POLYPEPTIDE SEQUENCES FOR PREPARING CYCLIZED POLYPEPTIDES
#191ADIPONECTIN GLYCOPEPTIDES AND COMPOSITIONS AND METHODS OF USE THEREOF
#192CNP compounds
#193NON-COVALENT HALOTAG LIGANDS
#194MODIFIED B-TYPE NATRIURETIC PEPTIDE
#195MODULAR DNA-BINDING DOMAINS AND METHODS OF USE
#196PROCOAGULANT PEPTIDES AND USE THEREOF
#197Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy
#198SYNTHETIC PEPTIDE SHUTTLE AGENT BIOCONJUGATES FOR INTRACELLULAR CARGO DELIVERY
#199BROAD SPECTRUM METALLOPROTEINASE INHIBITOR FOR THE TREATMENT OF SNAKEBITE
#200PEPTIDE PLATINUM COMPLEXES AND METHODS OF USE THEREOF
#201ANTIMICROBIAL CATIONIC PEPTOID AND N-SUBTITUTED PEPTIDIC COPOLYMERS, PREPARATION AND USES THEREOF
#202KEAP1/NRF2 PROTEIN-LIKE POLYMERS
#203STANDARD POLYPEPTIDES
#204Antimicrobial peptides and use of the same for treating microbial infections
#205PROTEINS AND USES THEREOF
#206CHEMOTACTIC AUTOPHAGY-INHIBITING PEPTIDE, COMPOSITIONS AND METHODS RELATED THERETO
#207PEPTIDIC POSITIVE ALLOSTERIC MODULATORS TARGETING TRPV1
#208SYNTHETIC PRE-PROTEIN SIGNAL PEPTIDES FOR DIRECTING SECRETION OF HETEROLOGOUS PROTEINS IN BACILLUS BACTERIA
#209METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPY 1
#210REGULATORY T CELL-INDUCING PEPTIDE AND COMPOSITION INCLUDING SAME FOR PREVENTING OR TREATING AUTOIMMUNE DISEASE
#211MeCP2 EXPRESSION CASSETTES
#212MULTIVALENT PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME
#213SYNTHETIC IL-7 AND IL-7 IMMUNOCYTOKINES
#214MULTIVALENT NANO-'SELF' PEPTIDES AND USES THEREOF
#215PEPTIDES FOR USE IN THE TREATMENT OR PREVENTION OF MYOCARDIAL DAMAGE
#216BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE MOIETIES AND USES THEREOF
#217NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF
#218MODULATORS OF MYC, METHODS OF USING THE SAME, AND METHODS OF IDENIFYING AGENTS THAT MODULATE MYC
#219PEPTIDE FOR PREVENTING OR TREATING INFLAMMATORY DISEASES
#220Charged Nutritive Proteins and Methods
#221FLUORESCENT COMPOUND COMPRISING A FLUOROPHORE CONJUGATED TO A pH-TRIGGERED POLYPEPTIDE
#222METHOD FOR PRODUCING DIPEPTIDE
#223Pharmaceutical compositions comprising WRN helicase inhibitors
#224Targets for Receptor-Mediated Control of Therapeutic Biodistribution and Efficacy
#225TREATMENT OF CVD AND SYSTEMIC SCEROSIS WITH BETA-1 ADRENERGIC RECEPTOR ANTIBODIES
#226ANTAGONIST OF INTERLEUKIN-17B RECEPTOR (IL-17RB) AND USE THEREOF
#227Compositions and Methods of Treatment Using CRRL 191
#228BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS
#229Synthetic system for tunable thresholding of protein signals
#230NEW POLYPEPTIDE
#231SELECTIVE MENA BINDING PEPTIDES
#232Novel Peptide Carrier Compositions
#233PREPARATION OF FUNCTIONAL HOMOCYSTEINE RESIDUES IN POLYPEPTIDES AND PEPTIDES
#234SYNTHETIC PLASMODIUM ANTIGENS, COMPOSITIONS, AND USES THEREOF
#235ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-RESPONSIVE BIOPOLYMER NETWORKS
#236Fluorescent compound comprising a fluorophore conjugated to a pH-triggered polypeptide
#237PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS
#238COMPOSITION FOR PREVENTION OR TREATMENT OF SARS-COV-2 INFECTION
#239PESTICIDAL GENES AND METHODS OF USE
#240SAP AND PEPTIDOMIMETIC COMPOSITIONS FOR REDUCING SYMPTOMS OF INFLAMMATION
#241ANTI-TUMOR PEPTIDE AND USE THEREOF
#242THERAPEUTIC PEPTIDES
#243CONDUCTIVE SYNTHETIC PEPTIDES FOR MOLECULAR ELECTRONICS
#244POLYPEPTIDES INCLUDING A BETA-TRICALCIUM PHOSPHATE-BINDING SEQUENCE AND USES THEREOF
#245SYNTHETIC DNA BINDING DOMAINS AND USES THEREOF
#246BYSTANDER PROTEIN VACCINES
#247SYNTHETIC PROTEIN-LEVEL NEURAL NETWORK IN MAMMALIAN CELLS
#248Optimized protein linkers and methods of use
#249TYROSYL-LOCK PEPTIDES
#250Antibody-peptide fusion proteins for treating amyloid disorders
#251PEPTIDE CONJUGATES OF PEPTIDIC TUBULIN INHIBITORS AS THERAPEUTICS
#252ENGINEERED CYCLIC PEPTIDES FOR ENHANCING VIRAL PRODUCTION
#253COMPOSITIONS OF EMBEDDED EPITOPE RANDOM PEPTIDES (EERP) FOR TREATMENT OF IMMUNE-MEDIATED CONDITIONS, AND METHODS OF USE
#254DNA-ENCODED AND AFFINITY-TAGGED MASKED-WARHEAD COMPOUNDS AND USE THEREOF IN ASSEMBLING LIBRARIES OF SMALL MOLECULES ENABLED FOR LATE-STAGE PURIFICATION AND MULTIPLEXED SCREENING OF COVALENT LIGANDS
#255PROCESS FOR PREPARING GLUCAGON-LIKE PEPTIDE-1
#256ANTIGEN BINDING DOMAIN WITH REDUCED CLIPPING RATE
#257CORONAVIRUS INFECTIOUS DISEASE COVID-19 THERAPEUTIC PROTEINS CTP ALPHA, CTP BETA, CTP GAMMA, CTP DELTA, AND USES THEREOF
#258METHOD FOR THE TREATMENT OF CANCER VIA TUMOR CELL LYSIS AND INTRATUMORAL ADMINISTRATION OF COMBINATIONS OF IMMUNOTHERAPEUTIC INGREDIENTS
#259Cell Permeable Proteins for Genome Engineering
#260AAV8 AFFINITY AGENTS
#261REGULATORS OF CELL DIVISION
#262METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#263RADIOLABELED LIGANDS FOR TARGETED PET/SPECT IMAGING AND METHODS OF THEIR USE
#264Inhibition of TREM receptor signaling with peptide variants
#265HUMAN IL23 RECEPTOR BINDING POLYPEPTIDES
#266NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#267METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#268METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#269Methods and compositions for prime editing nucleotide sequences
#270METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#271METHOD FOR PRODUCING SEMICONDUCTOR QUANTUM DOTS
#272Compositions and Methods of Treatment
#273SYNTHETIC PEPTIDES FOR DISSOLVING TAU INCLUSIONS
#274ANTIBODY FRAGMENT CONSISTING OF HEAVY CHAIN AND LIGHT CHAIN CONSTANT REGIONS IN WHICH GAMMA CONSTANT REGION (Cgamma1) AND EPSILON CONSTANT REGION (CE2-4) ARE FUSED, AND USE THEREOF
#275BIOACTIVE PEPTIDES HAVING DETRIMENTAL EFFECTS ON PEST SLUGS
#276PEPTIDE FOR TREATMENT OF CORONA VIRUS INFECTION DISEASE COVID-19 AND USE THEREOF
#277ARGININE FLUORESCENT PROBE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#278IMMUNOGLOBULIN BINDING PROTEINS FOR AFFINITY PURIFICATION
#279COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION, PEPTIDE AND USE IN THE REDUCTION AND ELIMINATION OF WRINKLES AND EXPRESSION LINES
#280BARCODED XTEN POLYPEPTIDES AND COMPOSITIONS THEREOF, AND METHODS FOR MAKING AND USING THE SAME
#281MODULAR AND GENERALIZABLE BIOSENSOR PLATFORM BASED ON DE NOVO DESIGNED PROTEIN SWITCHES
#282Control of Copolymer Compositions
#283Compositions and methods for reducing ice crystal formation
#284Polypeptide-antibody complexes and uses thereof
#285Repeat Protein Architectures
#286PEPTIDES AND METHODS OF USE
#287SERUM ALBUMIN-BINDING POLYPEPTIDES
#288NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#289CYTOKINE CONJUGATES
#290BLOOD-BRAIN BARRIER TRANSMIGRATING COMPOUNDS AND USES THEREOF
#291SARS-COV-2 inhibitors
#292Peptide Having Mesenchymal Stem Cell Mobilizing Activity
#293PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#294PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#295PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#296Wet adhesive peptides
#297NANOPARTICLE-LIKE DELIVERY SYSTEM
#298SYNTHETIC PROTEIN CIRCUITS DETECTING SIGNAL TRANSDUCER ACTIVITY
#299BROAD-SPECTRUM ANTIVIRAL PEPTIDES
#300PREPARATION METHOD AND APPLICATION OF INTERFERING PEPTIDE TARGETING SARS-CoV-2 N PROTEIN